Bringing down the ROS: a new therapeutic approach for PPHN.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Neonatal pulmonary hypertension.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2010
   Pooled it
2. Protection of oral hydrogen water as an antioxidant on pulmonary hypertension.Molecular biology reports · 2013
   Article
3. Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.Antioxidants & redox signaling · 2013
   Article
4. Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy.Pulmonary circulation · 2013
   Article
5. A process-based review of mouse models of pulmonary hypertension.Pulmonary circulation · 2012
   Article
6. Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.American journal of physiology. Lung cellular and molecular physiology · 2012
   Article
7. Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension.Molecular medicine (Cambridge, Mass.) · 2012
   Article
8. Therapeutic approaches using nitric oxide in infants and children.Free radical biology & medicine · 2011
   Review
9. Oxidative injury is a common consequence of BMPR2 mutations.Pulmonary circulation · 2011
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as